Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006057 |
---|---|
Receipt number | R000007170 |
Scientific Title | Cohort study of capecitabine plus oxaliplatin (XELOX) together with Bevacizumab as the first-line therapy in advance or recurrent colorectal cancer. |
Date of disclosure of the study information | 2011/08/01 |
Last modified on | 2011/07/28 10:18:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/07/28 10:19:46 |